The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer

por ZHANG, CHANG-HUA, AWASTHI, NIRANJAN, SCHWARZ, MARGARET A., SCHWARZ, RODERICH E.
Publicado 2013

Cell Proliferation and Migration Are Modulated by Cdk-1-Phosphorylated Endothelial-Monocyte Activating Polypeptide II

por Schwarz, Margaret A., Thornton, Janet, Xu, Haiming, Awasthi, Niranjan, Schwarz, Roderich E.
Publicado 2012

Evaluation of Poly-Mechanistic Antiangiogenic Combinations to Enhance Cytotoxic Therapy Response in Pancreatic Cancer

por Awasthi, Niranjan, Zhang, Changhua, Ruan, Winston, Schwarz, Margaret A., Schwarz, Roderich E.
Publicado 2012

Superior Antitumor Activity of Nanoparticle Albumin-Bound Paclitaxel in Experimental Gastric Cancer

por Zhang, Changhua, Awasthi, Niranjan, Schwarz, Margaret A., Hinz, Stefan, Schwarz, Roderich E.
Publicado 2013

Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II

por Awasthi, Niranjan, Zhang, Changhua, Hinz, Stefan, Schwarz, Margaret A, Schwarz, Roderich E
Publicado 2013

Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer

por Awasthi, Niranjan, Monahan, Sheena, Stefaniak, Alexis, Schwarz, Margaret A., Schwarz, Roderich E.
Publicado 2017

Enhancing gastric cancer conventional chemotherapy effects by triple angiokinase inhibitor nintedanib in preclinical models

por Awasthi, Niranjan, Schwarz, Margaret A., Kaurich, Quinn, Zhang, Changhua, Hilberg, Frank, Schwarz, Roderich E.
Publicado 2023

Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation

por Chen, Yao, Legan, Susan K, Mahan, Anne, Thornton, Janet, Xu, Haiming, Schwarz, Margaret A
Publicado 2012

Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer

por Awasthi, Niranjan, Kirane, Amanda, Schwarz, Margaret A, Toombs, Jason E, Brekken, Rolf A, Schwarz, Roderich E
Publicado 2011

Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models

por Awasthi, Niranjan, Scire, Emily, Monahan, Sheena, Grojean, Meghan, Zhang, Eric, Schwarz, Margaret A., Schwarz, Roderich E.
Publicado 2016

A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma

por Hassan, Md. Sazzad, Awasthi, Niranjan, Li, Jun, Schwarz, Margaret A., Schwarz, Roderich E., von Holzen, Urs
Publicado 2017

Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma

por Hassan, Md Sazzad, Awasthi, Niranjan, Li, Jun, Williams, Fiona, Schwarz, Margaret A., Schwarz, Roderich E., von Holzen, Urs
Publicado 2018

Therapeutic efficacy of anti‐MMP9 antibody in combination with nab‐paclitaxel‐based chemotherapy in pre‐clinical models of pancreatic cancer

por Awasthi, Niranjan, Mikels‐Vigdal, Amanda J., Stefanutti, Erin, Schwarz, Margaret A., Monahan, Sheena, Smith, Victoria, Schwarz, Roderich E.
Publicado 2019

Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma

por Hassan, Md. Sazzad, Williams, Fiona, Awasthi, Niranjan, Schwarz, Margaret A., Schwarz, Roderich E., Li, Jun, von Holzen, Urs
Publicado 2019

Cavin-3 dictates the balance between ERK and Akt signaling

por Hernandez, Victor J, Weng, Jian, Ly, Peter, Pompey, Shanica, Dong, Hongyun, Mishra, Lopa, Schwarz, Margaret, Anderson, Richard GW, Michaely, Peter
Publicado 2013

Targeted dual inhibition of c‐Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models

por Grojean, Meghan, Schwarz, Margaret A., Schwarz, Johann R., Hassan, Sazzad, von Holzen U, Zhang, Changhua, Schwarz, Roderich E., Awasthi, Niranjan
Publicado 2021

Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy

por Awasthi, Niranjan, Schwarz, Margaret A., Zhang, Changhua, Klinz, Stephan G., Meyer-Losic, Florence, Beaufils, Benjamin, Thiagalingam, Arunthathi, Schwarz, Roderich E.
Publicado 2022

Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer

por Hassan, Md Sazzad, Cwidak, Nicholas, Johnson, Chloe, Däster, Silvio, Eppenberger-Castori, Serenella, Awasthi, Niranjan, Li, Jun, Schwarz, Margaret A., von Holzen, Urs
Publicado 2021

Endothelial-Monocyte Activating Polypeptide Ii, a Novel Antitumor Cytokine That Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells

por Schwarz, Margaret A., Kandel, Jessica, Brett, Jerald, Li, Jun, Hayward, Joanne, Schwarz, Roderich E., Chappey, Olivier, Wautier, Jean-Luc, Chabot, John, Gerfo, Paul Lo, Stern, David
Publicado 1999